• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Clearmind Medicine Inc. - Common Shares (NQ:CMND)

    2.450 +0.010 (+0.41%)
    Streaming Delayed Price Updated: 4:00 PM EST, Jan 14, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,266,271
    Open 2.520
    Bid (Size) 2.390 (5,600)
    Ask (Size) 2.440 (100)
    Prev. Close 2.440
    Today's Range 2.121 - 2.630
    52wk Range 1.743 - 64.00
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Clearmind Medicine Announces Successful Completion of Treatment in All Patients of the Second Cohort in Ongoing Phase I/IIa Clinical Trial for CMND-100
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    News headline image
    Clearmind Medicine Regains Compliance with Nasdaq Minimum Bid Price Requirement
    From Clearmind Medicine Inc.
    Via GlobeNewswire

    Performance

    YTD
    +23.1%
    +23.1%
    1 Month
    -9.9%
    -9.9%
    3 Month
    -93.5%
    -93.5%
    6 Month
    -93.8%
    -93.8%
    1 Year
    -95.9%
    -95.9%

    More News

    Read More
    News headline image
    Clearmind Medicine Reflects on a Transformative 2025: Key Clinical Advancements, Expanded Global Reach, and Strengthened Foundation for Future Growth
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    News headline image
    Clearmind Medicine Announces Successful Completion of Second Cohort Enrollment in Ongoing FDA-Approved Phase I/IIa Trial for CMND-100
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    News headline image
    Clearmind Medicine's MEAI Spotlighted in Prestigious Review: Leading Experts Affirm Transformative Potential for Alcohol Use Disorder Treatment
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    News headline image
    Clearmind Medicine Successfully Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    News headline image
    Top movers analysis one hour before the close of the markets on 2025-12-11: top gainers and losers in today's session. ↗
    Via Chartmill
    News headline image
    Top stock movements in today's session. ↗
    Via Chartmill
    News headline image
    The market is filled with gapping stocks in Thursday's session. ↗
    Via Chartmill
    News headline image
    Get insights into the top gainers and losers of Thursday's pre-market session. ↗
    Via Chartmill
    News headline image
    Stay updated with the stocks that are on the move in today's after-hours session. ↗
    Via Chartmill
    News headline image
    Clearmind Medicine Announces 1-for-40 Reverse Share Split
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    News headline image
    Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    News headline image
    Which stocks are gapping on Wednesday? ↗
    Via Chartmill
    News headline image
    Get insights into the top gainers and losers of Wednesday's pre-market session. ↗
    Via Chartmill
    News headline image
    Curious about the most active stocks on Tuesday? ↗
    Via Chartmill
    News headline image
    Clearmind Medicine Advances CMND-100 to Dosing Phase at Hadassah Medical Center in Ongoing Phase I/IIa Clinical Trial for Alcohol Use Disorder
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    News headline image
    Clearmind Medicine Charges Forward in Alcoholism Treatment: Positive Cohort Data, Full DSMB Approval, and New Elite Site Joins the Clinical Trial
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    News headline image
    Clearmind Medicine Kicks-Off Patient Enrollment at Tel Aviv Sourasky Medical Center, Adding Another Site Activated in its in Phase I/IIa Alcohol Use Disorder Trial
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    News headline image
    Clearmind Medicine's Data and Safety Monitoring Board Unanimously Approves Continuation of Phase I/IIa Clinical Trial for CMND-100 Following Positive Interim Safety Review
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    News headline image
    SciSparc: Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression
    From SciSparc Ltd
    Via GlobeNewswire
    News headline image
    Clearmind Medicine Accelerate FDA-Approved Alcohol Use Disorder Clinical Trial by Activating Fifth Elite Global Medical Site
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    News headline image
    Tuesday's after hours session: top gainers and losers ↗
    Via Chartmill
    News headline image
    On Tuesday, there are stocks with unusual volume. Let's take a look. ↗
    Via Chartmill
    News headline image
    Clearmind Medicine Announces Positive Top-Line Results from First Cohort of its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder
    From Clearmind Medicine Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Clearmind Medicine Inc. - Common Shares publicly traded?
    Yes, Clearmind Medicine Inc. - Common Shares is publicly traded.
    What exchange does Clearmind Medicine Inc. - Common Shares trade on?
    Clearmind Medicine Inc. - Common Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Clearmind Medicine Inc. - Common Shares?
    The ticker symbol for Clearmind Medicine Inc. - Common Shares is CMND on the Nasdaq Stock Market
    What is the current price of Clearmind Medicine Inc. - Common Shares?
    The current price of Clearmind Medicine Inc. - Common Shares is 2.450
    When was Clearmind Medicine Inc. - Common Shares last traded?
    The last trade of Clearmind Medicine Inc. - Common Shares was at 01/14/26 04:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.